# ShanX MedTech awarded EUR 8.85M EU4Health contract for rapid AST

ShanX MedTech has been awarded an EU4Health contract worth EUR 8.85 million to lead a European joint tender developing a rapid point-of-care antimicrobial susceptibility test (AST). The contract was announced on December 18, 2025.

- Type: Contract
- Announced: 2025-12-18
- Value: $9.30M (8.85M EUR)
- Status: completed
- Products: rapid point-of-care antimicrobial susceptibility test
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [ShanX MedTech](https://endata.com/companies/89225.md) (supplier)

## Sources

- [shanxmedtech.com](https://shanxmedtech.com/eur885-m-usd104-m-contract-fuels-shanx-medtech-led-advances-in-point-of-care-ast/), 2025-12-18: "ShanX MedTech has been awarded an EU4Health contract to lead a European joint tender developing a rapid point-of-care (POC) antimicrobial susceptibility test, a critical step in the fight against antimicrobial resistance (AMR)."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.